DXR vs KMTS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
KMTS Captures Institutional Edge (2โ1 Pillars ยท 4โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Kestra Medical Technologies, Ltd. Common Stock (KMTS) driven by superior Growth & Margin, Momentum & Technical while DXR counters with relative strength in Valuation. Fundamentally, DXR trades at 64.5x Forward P/E with -5894.3% operating margin (+25.5% YoY revenue) versus KMTS at N/M Forward P/E and -134.5% operating margin (+59.9% YoY). In options structure, DXR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against KMTS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DXR | KMTS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $49.5M | $1.7B | Larger Scale | KMTS |
| Trailing P/E Ratio Valuation | 7.7x | N/M | Lower Multiple | DXR |
| Forward P/E Ratio Valuation | 64.5x | N/M | Lower Multiple | DXR |
| Revenue Growth (YoY) Growth | +25.5% | +59.9% | Higher Growth | KMTS |
| Operating Margin (TTM) Profitability | -5894.3% | -134.5% | Higher Margin | KMTS |
| Net Profit Margin Profitability | 19861.4% | -140.4% | Higher Margin | DXR |
| Return on Equity (ROE) Capital Efficiency | 14.2% | -73.7% | Higher ROE | DXR |
| 52-Week Range Position Momentum | 2% ($8โ$15) | 73% ($17โ$32) | Stronger Trend | KMTS |
| Beta / 30D Volatility Risk Regime | 0.28ฮฒ ยท 32% Vol | 1.84ฮฒ ยท 63% Vol | Lower Realized Risk | DXR |
| Unified Institutional Score Composite Signal | 52.2 / 100 (HOLD) | 43.8 / 100 (HOLD) | Higher Composite | DXR |